Quarterly report · Q2
2160.TEDINET S100P1F0
Period2022-01-01 → 2022-06-30
Filed2022-08-15
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥8.2bn | 2022-01-01 → 2022-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥4.2bn | 2022-04-01 → 2022-06-30d | Cons. | Revenue IFRS |
| Revenue | ¥12.7bn | 2021-01-01 → 2021-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥6.5bn | 2021-01-01 → 2021-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥2.6bn | 2021-04-01 → 2021-06-30d | Cons. | Revenue IFRS |
| Operating income | ¥1.0bn | 2022-01-01 → 2022-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥526m | 2022-04-01 → 2022-06-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥1.5bn | 2021-01-01 → 2021-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥682m | 2021-04-01 → 2021-06-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥790m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥443m | 2022-04-01 → 2022-06-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥1.1bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥1.2bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥522m | 2021-04-01 → 2021-06-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥676m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥325m | 2022-04-01 → 2022-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥1.1bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥941m | 2021-01-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥509m | 2021-04-01 → 2021-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥198m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥126m | 2022-04-01 → 2022-06-30d | Cons. | Profit loss IFRS |
| Net income | ¥55m | 2021-01-01 → 2021-12-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥745m | 2021-01-01 → 2021-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥309m | 2021-04-01 → 2021-06-30d | Cons. | Profit loss IFRS |
| Total assets | ¥35.3bn | at 2022-06-30 | Cons. | Assets IFRS |
| Total assets | ¥30.3bn | at 2021-12-31 | Cons. | Assets IFRS |
| Total assets | ¥29.0bn | at 2021-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥13.5bn | at 2022-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥11.0bn | at 2021-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥21.8bn | at 2022-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥19.3bn | at 2021-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥19.1bn | at 2021-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥12.8bn | at 2020-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥22.0bn | at 2022-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥18.9bn | at 2021-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥17.9bn | at 2021-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥14.5bn | at 2022-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥14.4bn | at 2021-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥13.8bn | at 2021-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥10.3bn | at 2020-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥389m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥552m | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥1.1bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥1.5bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥261m | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥1.0bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥267m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥2.9bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥2.9bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥14.25 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥6.86 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥22.72 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥20.3 | 2021-01-01 → 2021-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥10.78 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥14.18 | 2022-01-01 → 2022-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥6.83 | 2022-04-01 → 2022-06-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥22.08 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥19.73 | 2021-01-01 → 2021-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥10.59 | 2021-04-01 → 2021-06-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 62.5% | at 2022-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 62.3% | at 2021-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 61.9% | at 2021-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥526m |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥7.0bn |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥7.0bn |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥479m |
| —segment total | revenue | 2022-01-01 → 2022-06-30 | ¥8.2bn |
| —segment total | revenue external | 2022-01-01 → 2022-06-30 | ¥8.2bn |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥1.0bn |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥1.0bn |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥1.0bn |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥390m |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥5.5bn |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥5.5bn |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥1.1bn |
| —segment total | revenue | 2021-01-01 → 2021-06-30 | ¥6.5bn |
| —segment total | revenue external | 2021-01-01 → 2021-06-30 | ¥6.5bn |
| —segment total | segment profit | 2021-01-01 → 2021-06-30 | ¥1.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 734
| Item | Context | Value | Unit |
|---|---|---|---|
| Change in scope of consolidation ss IFRS | Prior1YTDDuration_RetainedEarningsIFRSMember | － | JPY |
| Change in scope of consolidation ss IFRS | Prior1YTDDuration_ShareAcquisitionRightsIFRSMember | － | JPY |
| Change in scope of consolidation ss IFRS | Prior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | － | JPY |
| Change in scope of consolidation ss IFRS | Prior1YTDDuration_OtherComponentsOfEquityIFRSMember | － | JPY |
| Dividends ss IFRS | Prior1YTDDuration_ShareCapitalIFRSMember | － | JPY |
| Dividends ss IFRS | Prior1YTDDuration_CapitalSurplusIFRSMember | － | JPY |
| Dividends ss IFRS | Prior1YTDDuration_TreasurySharesIFRSMember | － | JPY |
| Dividends ss IFRS | Prior1YTDDuration_RetainedEarningsIFRSMember | -150838000 | JPY |
| Dividends ss IFRS | Prior1YTDDuration_ShareAcquisitionRightsIFRSMember | － | JPY |
| Dividends ss IFRS | Prior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | － | JPY |
| Dividends ss IFRS | Prior1YTDDuration_OtherComponentsOfEquityIFRSMember | － | JPY |
| Issuance of new shares ss IFRS | Prior1YTDDuration_ShareCapitalIFRSMember | 2615859000 | JPY |
| Issuance of new shares ss IFRS | Prior1YTDDuration_CapitalSurplusIFRSMember | 2615859000 | JPY |
| Issuance of new shares ss IFRS | Prior1YTDDuration_TreasurySharesIFRSMember | － | JPY |
| Issuance of new shares ss IFRS | Prior1YTDDuration_RetainedEarningsIFRSMember | － | JPY |
| Issuance of new shares ss IFRS | Prior1YTDDuration_ShareAcquisitionRightsIFRSMember | -12930000 | JPY |
| Issuance of new shares ss IFRS | Prior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | － | JPY |
| Issuance of new shares ss IFRS | Prior1YTDDuration_OtherComponentsOfEquityIFRSMember | -12930000 | JPY |
| Issuance of share acquisition rights ss IFRS | Prior1YTDDuration_ShareCapitalIFRSMember | － | JPY |
| Issuance of share acquisition rights ss IFRS | Prior1YTDDuration_CapitalSurplusIFRSMember | － | JPY |
| Issuance of share acquisition rights ss IFRS | Prior1YTDDuration_TreasurySharesIFRSMember | － | JPY |
| Issuance of share acquisition rights ss IFRS | Prior1YTDDuration_RetainedEarningsIFRSMember | － | JPY |
| Issuance of share acquisition rights ss IFRS | Prior1YTDDuration_ShareAcquisitionRightsIFRSMember | 58659000 | JPY |
| Issuance of share acquisition rights ss IFRS | Prior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | － | JPY |
| Issuance of share acquisition rights ss IFRS | Prior1YTDDuration_OtherComponentsOfEquityIFRSMember | 58659000 | JPY |
| Share based payment transactions ss IFRS | Prior1YTDDuration_ShareCapitalIFRSMember | － | JPY |
| Share based payment transactions ss IFRS | Prior1YTDDuration_CapitalSurplusIFRSMember | － | JPY |
| Share based payment transactions ss IFRS | Prior1YTDDuration_TreasurySharesIFRSMember | － | JPY |
| Share based payment transactions ss IFRS | Prior1YTDDuration_RetainedEarningsIFRSMember | － | JPY |
| Share based payment transactions ss IFRS | Prior1YTDDuration_ShareAcquisitionRightsIFRSMember | 82469000 | JPY |
| Share based payment transactions ss IFRS | Prior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | － | JPY |
| Share based payment transactions ss IFRS | Prior1YTDDuration_OtherComponentsOfEquityIFRSMember | 82469000 | JPY |
| Issuance of stocks ss IFRS | Prior1YTDDuration_ShareCapitalIFRSMember | － | JPY |
| Issuance of stocks ss IFRS | Prior1YTDDuration_CapitalSurplusIFRSMember | -18772000 | JPY |
| Issuance of stocks ss IFRS | Prior1YTDDuration_TreasurySharesIFRSMember | － | JPY |
| Issuance of stocks ss IFRS | Prior1YTDDuration_RetainedEarningsIFRSMember | － | JPY |
| Issuance of stocks ss IFRS | Prior1YTDDuration_ShareAcquisitionRightsIFRSMember | － | JPY |
| Issuance of stocks ss IFRS | Prior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | － | JPY |
| Issuance of stocks ss IFRS | Prior1YTDDuration_OtherComponentsOfEquityIFRSMember | － | JPY |
| Srs issuance cost IFRS | Prior1YTDDuration_ShareCapitalIFRSMember | － | JPY |
| Srs issuance cost IFRS | Prior1YTDDuration_CapitalSurplusIFRSMember | － | JPY |
| Srs issuance cost IFRS | Prior1YTDDuration_TreasurySharesIFRSMember | － | JPY |
| Srs issuance cost IFRS | Prior1YTDDuration_RetainedEarningsIFRSMember | － | JPY |
| Srs issuance cost IFRS | Prior1YTDDuration_ShareAcquisitionRightsIFRSMember | -3719000 | JPY |
| Srs issuance cost IFRS | Prior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | － | JPY |
| Srs issuance cost IFRS | Prior1YTDDuration_OtherComponentsOfEquityIFRSMember | -3719000 | JPY |
| Purchase of treasury shares ss IFRS | Prior1YTDDuration_ShareCapitalIFRSMember | － | JPY |
| Purchase of treasury shares ss IFRS | Prior1YTDDuration_CapitalSurplusIFRSMember | － | JPY |
| Purchase of treasury shares ss IFRS | Prior1YTDDuration_TreasurySharesIFRSMember | -95000 | JPY |
| Purchase of treasury shares ss IFRS | Prior1YTDDuration_RetainedEarningsIFRSMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |